[1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
doi: 10.3322/caac.21660
|
[2] |
Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J (Engl), 2022, 135(5): 584-590. DOI: 10.1097/CM9.0000000000002108.
doi: 10.1097/CM9.0000000000002108
|
[3] |
Salimzadeh H, Lindskog EB, Gustavsson B, et al. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival[J]. BMC Cancer, 2020, 20(1): 409. DOI: 10.1186/s12885-020-06924-z.
doi: 10.1186/s12885-020-06924-z
pmid: 32397974
|
[4] |
Chan JCY, Diakos CI, Chan DLH, et al. A longitudinal investigation of inflammatory markers in colorectal cancer patients perioperatively demonstrates benefit in serial remeasurement[J]. Ann Surg, 2018, 267(6): 1119-1125. DOI: 10.1097/SLA.0000000000002251.
doi: 10.1097/SLA.0000000000002251
pmid: 28394869
|
[5] |
Dolan RD, McSorley ST, Park JH, et al. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores[J]. Br J Cancer, 2018, 119(1): 40-51. DOI: 10.1038/s41416-018-0095-9.
doi: 10.1038/s41416-018-0095-9
|
[6] |
Chen JH, Zhai ET, Yuan YJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer[J]. World J Gastroenterol, 2017, 23(34): 6261-6272. DOI: 10.3748/wjg.v23.i34.6261.
doi: 10.3748/wjg.v23.i34.6261
|
[7] |
Verter E, Berger Y, Perl G, et al. Neutrophil-to-lymphocyte ratio predicts recurrence pattern in patients with resectable colorectal liver metastases[J]. Ann Surg Oncol, 2021, 28(8): 4320-4329. DOI: 10.1245/s10434-021-10000-6.
doi: 10.1245/s10434-021-10000-6
|
[8] |
Thanikachalam K, Khan G. Colorectal cancer and nutrition[J]. Nutrients, 2019, 11(1): 164. DOI: 10.3390/nu11010164.
doi: 10.3390/nu11010164
|
[9] |
Yamamoto T, Kawada K, Obama K. Inflammation-related biomar-kers for the prediction of prognosis in colorectal cancer patients[J]. Int J Mol Sci, 2021, 22(15): 8002. DOI: 10.3390/ijms22158002.
doi: 10.3390/ijms22158002
|
[10] |
Tian G, Li G, Guan L, et al. Pretreatment albumin-to-alkaline phosphatase ratio as a prognostic indicator in solid cancers: a meta-analysis with trial sequential analysis[J]. Int J Surg, 2020, 81: 66-73. DOI: 10.1016/j.ijsu.2020.07.024.
doi: S1743-9191(20)30559-8
pmid: 32745716
|
[11] |
An L, Yin WT, Sun DW. Albumin-to-alkaline phosphatase ratio as a promising indicator of prognosis in human cancers: is it possible?[J]. BMC Cancer, 2021, 21(1): 247. DOI: 10.1186/s12885-021-07921-6.
doi: 10.1186/s12885-021-07921-6
pmid: 33685425
|
[12] |
Wang F, He W, Jiang C, et al. Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer[J]. BMC Cancer, 2018, 18(1): 1102. DOI: 10.1186/s12885-018-4842-3.
doi: 10.1186/s12885-018-4842-3
pmid: 30419863
|
[13] |
Cassetta L, Fragkogianni S, Sims AH, et al. Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets[J]. Cancer Cell, 2019, 35(4): 588-602, e10. DOI: 10.1016/j.ccell.2019.02.009.
doi: S1535-6108(19)30104-7
pmid: 30930117
|
[14] |
Kemp SB, Steele NG, Carpenter ES, et al. Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages[J]. Life Sci Alliance, 2021, 4(6): e202000935. DOI: 10.26508/lsa.202000935.
doi: 10.26508/lsa.202000935
|
[15] |
Sasaki A, Kai S, Endo Y, et al. Prognostic value of preoperative peripheral blood monocyte count in patients with colorectal liver metastasis after liver resection[J]. J Gastrointest Surg, 2007, 11(5): 596-602. DOI: 10.1007/s11605-007-0140-0.
doi: 10.1007/s11605-007-0140-0
pmid: 17468918
|
[16] |
Chan JC, Chan DL, Diakos CI, et al. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer[J]. Ann Surg, 2017, 265(3): 539-546. DOI: 10.1097/SLA.0000000000001743.
doi: 10.1097/SLA.0000000000001743
pmid: 27070934
|
[17] |
Li Y, Jia H, Yu W, et al. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection[J]. Int J Cancer, 2016, 139(1): 220-231. DOI: 10.1002/ijc.30071.
doi: 10.1002/ijc.30071
pmid: 26933932
|
[18] |
Suzuki Y, Okabayashi K, Hasegawa H, et al. Comparison of preoperative inflammation-based prognostic scores in patients with colorectal cancer[J]. Ann Surg, 2018, 267(3): 527-531. DOI: 10.1097/SLA.0000000000002115.
doi: 10.1097/SLA.0000000000002115
pmid: 27984214
|